Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: A mathematical modelling study

PLoS Neglected Tropical Diseases

Volumn 4, Issue 11, 2010, Pages

  French, Michael D ^a   Churcher, Thomas S ^a   Gambhir, Manoj ^a   Fenwick, Alan ^a   Webster, Joanne P ^a   Kabatereine, Narcis B ^b   Basáñez, Maria Gloria ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MINISTRY OF HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; HEALTH PROGRAM; IMMUNITY; LONGITUDINAL STUDY; MATHEMATICAL MODEL; MORBIDITY; PARASITE TRANSMISSION; REINFECTION; SCHISTOSOMIASIS MANSONI; TREND STUDY; UGANDA; ADOLESCENT; ADULT; ANIMAL; CHILD; DISEASE TRANSMISSION; DRUG EFFECT; FECES; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; PARASITOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SCHISTOSOMA MANSONI; THEORETICAL MODEL;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, THEORETICAL; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; UGANDA; YOUNG ADULT;

EID: 78649765421     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000897     Document Type: Article

References (67)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. Crompton DW, Savioli L (2007) Handbook of helminthiasis for public health. Boca Raton, Florida: Taylor and Francis.
3. Kumar V, Gryseels B (1994) Use of praziquantel against schistosomiasis: a review of current status. Int J Antimicrob Agents 4: 313-320.
4. Butterworth AE, Sturrock RF, Ouma JH, Mbugua GG, Fulford AJ, et al. (1991) Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology 103: 339-355.
5. Chan MS, Guyatt HL, Bundy DA, Medley GF (1996) Dynamic models of schistosomiasis morbidity. Am J Trop Med Hyg 55: 52-62.
6. Richter J (2003) The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 86: 161-183.
7. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, et al. (2007) Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 85: 91-99.
8. Koukounari A, Gabrielli AF, Toure ́ S, Bosque ́-Oliva E, Zhang Y, et al. (2007) Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 196: 659-669.
9. Stothard JR, French MD, Khamis IS, Basáñez MG, Rollinson D (2009) The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar. Trans R Soc Trop Med Hyg 103: 1031-1044.
10. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. (2009) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
11. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L (2006) The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol 22: 332-339.
12. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A (2009) Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 136: 1789-1799.
13. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, et al. (2007) Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 85: 91-99.
14. Kabatereine NB, Tukahebwa E, Kazibwe F, Namwangye H, Zaramba S, et al. (2006) Progress towards countrywide control of schistosomiasis and soiltransmitted helminthiasis in Uganda. Trans R Soc Trop Med Hyg 100: 208-215.
15. Butterworth AE, Fulford AJ, Dunne DW, Ouma JH, Sturrock RF (1988) Longitudinal studies on human schistosomiasis. Philos Trans R Soc Lond B Biol Sci 321: 495-511.
16. Woolhouse ME, Taylor P, Matanhire D, Chandiwana SK (1991) Acquired immunity and epidemiology of Schistosoma haematobium. Nature 351: 757-759.
17. Fulford AJ, Butterworth AE, Sturrock RF, Ouma JH (1992) On the use of ageintensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 105: 219-227.
18. Chan MS, Guyatt HL, Bundy DAP, Booth M, Fulford AJ, et al. (1995) The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect 115: 325-344.
19. Chan MS, Montresor A, Savioli L, Bundy DAP (1999) Planning chemotherapy based schistosomiasis control: validation of a mathematical model using data on Schistosoma haematobium from Pemba, Tanzania. Epidemiol Infect 123: 487-497.
20. Chan MS, Nsowah-Nuamah NN, Adjei S, Wen ST, Hall A, et al. (1998) Predicting the impact of school-based treatment for urinary schistosomiasis given by the Ghana Partnership for Child Development. Trans R Soc Trop Med Hyg 92: 386-389.
21. Woolhouse ME (1991) On the application of mathematical models of schistosome transmission dynamics. I. Natural transmission. Acta Trop 49: 241-270.
22. Churcher TS, Filipe JAN, Basáñez MG (2006) Density dependence and the control of helminth parasites. J Anim Ecol 75: 1313-1320.
23. Fulford AJ, Butterworth AE, Ouma JH, Sturrock RF (1995) A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology 110: 307-316.
24. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Geneva: World Health Organization. i-v1 p.
25. Montresor A, Crompton DW, Gyorkos T, Savioli L (2002) Helminth control in school-age children. A guide for managers of control programmes. Geneva: World Health Organization.
26. Fulford AJ (1994) Dispersion and bias: can we trust geometric means? Parasitology Today 10: 446-448.
27. Mutapi F, Gryseels B, Roddam A (2003) On the calculation of intestinal schistosome infection intensity. Acta Trop 87: 225-233.
28. Kirkwood BR, Sterne JAC (2003) Essential Medical Statistics. Oxford, U.K.: Blackwell Science Limited.
29. Good P (2005) Introduction to Statistics through Resampling Methods and R/SPLUS. Berlin:Wiley-Interscience. Springer Berlin.
30. Anderson RM, May RM (1991) Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press.
31. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, et al. (2007) Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 5: 27.
32. Bosompem KM, Bentum IA, Otchere J, Anyan WK, Brown CA, et al. (2004) Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health 9: 917-922.
33. Jordan P, Webbe G (1982) Schistosomiasis: epidemiology, treatment and control. London: William Heinemann.
34. Odogwu SE, Ramamurthy NK, Kabatereine NB, Kazibwe F, Tukahebwa E, et al. (2006) Schistosoma mansoni in infants (aged,3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 100: 315-326.
35. Garba A, Bakiré A, Djibo A, Lamine MS, Sofo B, et al. (2010) Revealing a neglected public health burden of schistosomiasis: infection of Schistosoma in infants and preschool aged children in a single Schistosoma haematobium and a mixed S.haematobium: S. mansoni foci of Niger. Acta Trop 115: 212-219.
36. Sturrock RF, Bensted-Smith R, Butterworth AE, Dalton PR, Kariuki HC, et al. (1987) Immunity after treatment of human schistosomiasis mansoni. III. Longterm effects of treatment and retreatment. Trans R Soc Trop Med Hyg 81: 303-314.
37. Chan MS, Anderson RM, Medley GF, Bundy DAP (1996) Dynamic aspects of morbidity and acquired immunity in schistosomiasis control. Acta Trop 62: 105-117.
38. Woolhouse ME (1992) On the application of mathematical models of schistosome transmission dynamics. II. Control. Acta Trop 50: 189-204.
39. Butterworth AE, Dunne DW, Fulford AJ, Thorne KJ, Gachuhi K, et al. (1992) Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunol Invest 21: 391-407.
40. Hagan P, Ndhlovu PD, Dunne DW (1998) Schistosome immunology: more questions than answers. Parasitology Today 14: 407-412.
41. Butterworth AE, Curry AJ, Dunne DW, Fulford AJ, Kimani G, et al. (1994) Immunity and morbidity in human schistosomiasis mansoni. Trop Geogr Med 46: 197-208.
42. Medley GF, Anderson RM (1985) Density-dependent fecundity in Schistosoma mansoni infections in man. Trans R Soc Trop Med Hyg 79: 532-534.
43. Williams BG, Dye C (1994) Maximum likelihood for parasitologists. Parasitology Today 10: 489-493.
44. Chan MS, Guyatt HL, Bundy DAP, Medley GF (1996) Dynamic models of schistosomiasis morbidity. Am J Trop Med Hyg 55: 52-62.
45. Blower SM, Dowlatabadi H (1994) Sensitivity and uncertainty analysis of complex models of disease transmission - an HIV model, as an example. International Statistical Review 62: 229-243.
46. Box GE, Jenkins GM (1976) Time Series Analysis: Forecasting and Control. San Francisco: Holden.
47. Bolker B (2008) Ecological Models and Data in R. Princeton University Press.
48. United States CB (2005) U.S. Census Bureau International Data Base. pp. http://www.census.gov/ipc/www/idb/country.php.
49. Miguel E, Kremer M (2004) Worms: identifying impacts on education and health in the presence of treatment externalities. Econometrica 72: 159-217.
50. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, et al. (1992) Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 22: 1483-1494.
51. Roberts M, Butterworth AE, Kimani G, Kamau T, Fulford AJ, et al. (1993) Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 61: 4984-4993.
52. Mutapi F (2001) Heterogeneities in anti-schistosome humoral responses following chemotherapy. Trends Parasitol 17: 518-524.
53. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, et al. (1992) Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg 47: 156-169.
54. Basáñez MG, Collins RC, Porter CH, Little MP, Brandling-Bennett D (2002) Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am J Trop Med Hyg 67: 669-679.
55. Davies CM, Webster JP, Woolhouse ME (2001) Trade-offs in the evolution of virulence in an indirectly transmitted macroparasite. Proc Biol Sci 268: 251-257.
56. Gower CM, Webster JP (2004) Fitness of indirectly transmitted pathogens: restraint and constraint. Evolution 58: 1178-1184.
57. Koukounari A, Fenwick A, Whawell S, Kabatereine NB, Kazibwe F, et al. (2006) Morbidity indicators of Schistoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am J Trop Med Hyg 75: 278-286.
58. Mupfasoni D, Karibushi B, Koukounari A, Ruberanziza E, Kaberuka T, et al. (2009) Polyparasite helminth infections and their association to anaemia and undernutrition in northern rwanda. PLoS Negl Trop Dis 3: e517.
59. Sousa-Figueiredo JC, Basáñez MG, Mgeni AF, Khamis IS, Rollinson D, et al. (2008) A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann Trop Med Parasitol 102: 679-692.
60. Sturrock RF, Kinyanjui H, Thiongo FW, Tosha S, Ouma JH, et al. (1990) Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya. Trans R Soc Trop Med Hyg 84: 257-261.
61. Sturrock RF, Klumpp RK, Ouma JH, Butterworth AE, Fulford AJ, et al. (1994) Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry. Parasitology 109: 443-453.
62. Yaméogo L, Toé L, Hougard J-M, Boatin BA, Unnasch TT (1999) Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnsoum sensu lato: results of a field trial in an area subject to successful vector control. Am J Trop Med Hyg 60: 124-128.
63. Appleton CC, Ellery WN, Byskov J, Mogkweetsinyana SS (2008) Epidemic transmission of intestinal schistosomiasis in the seasonal part of the Okavango Delta, Botswana. Ann Trop Med Parasitol 102: 611-623.
64. Useh MF, Ejezie GC (1999) School-based schistosomiasis control programmes: a comparative study on the prevalence and intensity of urinary schistosomiasis among Nigerian school-age children in and out of school. Trans R Soc Trop Med Hyg 93: 387-391.
65. Olsen A (1998) The proportion of helminth infections in a community in western Kenya which would be treated by mass chemotherapy of schoolchildren. Trans R Soc Trop Med Hyg 92: 144-148.
66. Hussein MH, Talaat M, El-Sayed MK, El-Badawi A, Evans DB (1996) Who misses out with school-based health programmes? A study of schistosomiasis control in Egypt. Trans R Soc Trop Med Hyg 90: 362-365.
67. Mekheimar SI, Talaat M (2005) School non-enrollment and its relation with health and schistosomiasis knowledge, attitudes and practices in rural Egypt. East Mediterr Health J 11: 392-401.